Similar articles

• Diagnosis and treatment of acquired haemophilia.

  Baudo F, Caimi T, de Cataldo F. Baudo F, et al. Haemophilia. 2010 May;16(102):102-6. doi: 10.1111/j.1365-2516.2010.02232.x. Haemophilia. 2010. PMID: 20536992
• Sequential therapy with activated prothrombin complex concentrate (FEIBA) and recombinant factor VIIa in a patient with severe haemophilia A, inhibitor presence and refractory bleeding.

  Economou M, Teli A, Tzantzaroudi A, Tsatra I, Zavitsanakis A, Athanassiou-Metaxa M. Economou M, et al. Haemophilia. 2008 Mar;14(2):390-1. doi: 10.1111/j.1365-2516.2007.01635.x. Epub 2008 Jan 10. Haemophilia. 2008. PMID: 18194305 No abstract available.
• Acquired hemophilia a: retrospective analysis of 49 cases from a single Chinese hemophilia center.

  Yang Y, Xue F, Shi H, Wang H, Zhang L, Ji L, Yang R. Yang Y, et al. Clin Appl Thromb Hemost. 2015 Jan;21(1):35-40. doi: 10.1177/1076029613488937. Epub 2013 May 14. Clin Appl Thromb Hemost. 2015. PMID: 23677912
• [Hemophilia A with factor VIII inhibitor].

  Shima M. Shima M. Rinsho Ketsueki. 2003 Feb;44(2):90-101. Rinsho Ketsueki. 2003. PMID: 12692981 Review. Japanese. No abstract available.
• From theory to practice: applying current clinical knowledge and treatment strategies to the care of hemophilia a patients with inhibitors.

  Gomperts ED, Astermark J, Gringeri A, Teitel J. Gomperts ED, et al. Blood Rev. 2008 Feb;22 Suppl 1:S1-11. doi: 10.1016/S0268-960X(08)70001-8. Blood Rev. 2008. PMID: 18485996 Review.